Release behavior and signaling effect of vitamin D3 in layered double hydroxides-hydroxyapatite/gelatin bone tissue engineering scaffold: An in vitro evaluation

被引:47
作者
Fayyazbakhsh, Fateme [1 ]
Solati-Hashjin, Mehran [1 ,2 ]
Keshtkar, Abbas [3 ]
Shokrgozar, Mohammad Ali [4 ]
Dehghan, Mohammad Mehdi [5 ]
Larijani, Bagher [6 ]
机构
[1] Amirkabir Univ Technol, Biomed Engn Fac, Tehran, Iran
[2] Amirkabir Univ Technol, Biomat Ctr Excellence, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Sci Educ Dev, Tehran, Iran
[4] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran
[5] Univ Tehran, Dept Surg & Radiol, Fac Vet Med, Tehran, Iran
[6] Univ Tehran Med Sci, Endocrinol & Metabolism Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran
关键词
Vitamin D3; Gelatin; Hydroxyapatite; Layered double hydroxides; Controlled release; Scaffold; Signaling; ALKALINE-PHOSPHATASE ACTIVITY; GELATIN NANOPARTICLES; DELIVERY-SYSTEM; CARRIER OIL; PHYSICOCHEMICAL PROPERTIES; NANOEMULSIONS INFLUENCE; CELL-PROLIFERATION; DRUG; FTIR; BIOACCESSIBILITY;
D O I
10.1016/j.colsurfb.2017.07.004
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Incorporating the controlled release of vitamin D3 (VD3) into biodegradable porous scaffolds is a new approach to equipping multifunctional therapeutics for osteoporosis. The current investigation involves the encapsulation of VD3 into gelatin through the one-step desolvation method. The layered double hydroxides-hydroxyapatite nanocomposite (LDH-HAp) and pure LDH were combined with the gelatin-VD3 complex to reinforce the porous biodegradable structure and enhance the biological response. Afterwards, glutaraldehyde was used to form crosslinks within the gelatin chains. The encapsulation efficiency and loading capacity showed approximately 40% and 50% reduction after crosslinking, respectively. The particle size, zeta potential, contact angle, Young's modulus and porosity were measured to find the effect of VD3 on the scaffolds' physiochemical properties. To explore the bioactivity and degradation behavior, the scaffolds were immersed in simulated body fluid. The VD3 release kinetics followed the Korsmeyer-Peppas model and non-Fickian release pattern. The greater osteblastic expression was observed in VD3-containing scaffolds due to the higher alkaline phosphatase activity which was excited more by HAp (P<0.05). Alizarin red staining illustrated that VD3 induced more calcium deposition, which indicates the signaling role of VD3 on osteoconductivity and biomineralization. The findings provide new insights on the VD3 encapsulation within hydrophilic matrices to protect VD3 and enable the signaling ability for bone tissue engineering scaffolds, which could improve the bone healing efficiency. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:697 / 708
页数:12
相关论文
共 87 条
[1]   Update in Vitamin D [J].
Adams, John S. ;
Hewison, Martin .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (02) :471-478
[2]  
[Anonymous], 2007, F215007 ASTM
[3]  
Azimi Bahareh, 2014, Iranian Biomedical Journal, V18, P34, DOI 10.6091/ibj.12422.2013
[4]   Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate [J].
Bajpai, AK ;
Choubey, J .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2006, 17 (04) :345-358
[5]   Effect of dispersion stirring speed on the particle size distribution and rheological properties of carbomer dispersions and gels [J].
Baudonnet, L ;
Pere, D ;
Michaud, P ;
Grossiord, JL ;
Rodriguez, F .
JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 2002, 23 (04) :499-510
[6]   A CRITICAL-REVIEW OF THE TOXICOLOGY OF GLUTARALDEHYDE [J].
BEAUCHAMP, RO ;
STCLAIR, MBG ;
FENNELL, TR ;
CLARKE, DO ;
MORGAN, KT ;
KARI, FW .
CRITICAL REVIEWS IN TOXICOLOGY, 1992, 22 (3-4) :143-174
[7]   Preanalytical, analytical (DiaSorin LIAISON) and clinical variables potentially affecting the 25-OH Vitamin D estimation [J].
Bianchi, Sara ;
Maffei, Silvia ;
Prontera, Concetta ;
Battaglia, Debora ;
Vassalle, Cristina .
CLINICAL BIOCHEMISTRY, 2012, 45 (18) :1652-1657
[8]   Treatment of early caries lesions using biomimetic self-assembling peptides - a clinical safety trial [J].
Brunton, P. A. ;
Davies, R. P. W. ;
Burke, J. L. ;
Smith, A. ;
Aggeli, A. ;
Brookes, S. J. ;
Kirkham, J. .
BRITISH DENTAL JOURNAL, 2013, 215 (04) :E6-E6
[9]   COMPRESSIVE BEHAVIOR OF BONE AS A 2-PHASE POROUS STRUCTURE [J].
CARTER, DR ;
HAYES, WC .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1977, 59 (07) :954-962
[10]   Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate [J].
Cascone, MG ;
Lazzeri, L ;
Carmignani, C ;
Zhu, ZH .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2002, 13 (05) :523-526